Poultry Medicine Market to Grow with a CAGR of 6.84% through 2030
Increasing
adoption of advanced veterinary pharmaceuticals and rising awareness about
poultry health management, is expected to drive the Global Poultry
Medicine Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Poultry Medicine Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Poultry Medicine Market stood at USD
6.78 Billion in 2024 and is expected to reach USD 10.10 Billion by
2030 with a CAGR of 6.84% during the forecast period. The Global Poultry
Medicine Market is expanding rapidly as the industry adapts to evolving
production practices and heightened emphasis on food safety. With poultry
farming becoming increasingly industrialized, there is growing reliance on
veterinary medicines to safeguard flock health and improve yield efficiency.
Rising consumer demand for antibiotic-free poultry products has also pushed
producers to explore innovative solutions that ensure both animal welfare and
product quality. Continuous advancements in biologics, anti-parasitic agents,
and nutritional supplements are further strengthening the adoption of
specialized medicines that cater to diverse poultry health needs. Increasing
integration of healthcare solutions into modern poultry production systems is
setting the stage for strong market momentum in the coming years.
The market is
being influenced by changing dynamics in poultry management practices and
global consumer preferences. Demand for sustainable farming practices has
encouraged producers to implement preventive healthcare strategies rather than
relying solely on curative medicines. The adoption of precision farming
technologies is also driving the use of data-driven veterinary solutions that
enable targeted treatment and better monitoring of flock health. Growing focus
on reducing production losses through disease prevention, improved immunity,
and feed optimization is reshaping product portfolios within the poultry
medicine sector. Collaborations between pharmaceutical companies and poultry
producers to develop customized health programs are becoming an important
trend, highlighting the market’s shift toward more integrated approaches.
Growth
opportunities in the Global Poultry Medicine Market lie in innovation,
partnerships, and untapped regions. Increasing demand for organic and
antibiotic-free poultry products is driving interest in herbal, plant-based,
and probiotic medicines, offering a lucrative space for manufacturers to
diversify their product lines. Expanding poultry production in emerging
economies, coupled with rising investments in modern farming infrastructure,
opens pathways for medicine companies to penetrate new customer bases. The
integration of artificial intelligence and digital health monitoring tools into
poultry farming presents further opportunities for precision treatment and
disease prevention. Strategic collaborations between veterinary research
institutions and pharmaceutical firms will accelerate the development of
advanced medicines, positioning the industry for robust growth over the
forecast period.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Poultry Medicine Market”
The Global Poultry
Medicine Market is segmented into species, product, disease, distribution
channel, regional distribution, and company.
Based on the Disease,
Infectious Bronchitis emerged as the fastest growing segment in the Global Poultry
Medicine Market during the forecast period. This is driven by the rising prevalence and
economic impact of this highly contagious respiratory infection in poultry.
Infectious bronchitis, caused by the avian coronavirus, spreads rapidly among
chicken flocks, leading to respiratory distress, reduced feed efficiency,
decreased egg production, and compromised egg quality. Its ability to mutate
into multiple serotypes makes prevention and control highly challenging,
thereby increasing the demand for effective medicines and vaccines. The rapid
growth of this segment is supported by the growing reliance on vaccination
programs as the primary strategy to control outbreaks. Poultry producers are
increasingly adopting advanced, multivalent vaccines that offer broader
protection against multiple strains of the virus. Rising awareness about the
significant production losses associated with infectious bronchitis has further
encouraged investment in preventive healthcare.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Poultry Medicine Market during
the forecast period. This is due to the shift toward sustainable and
residue-free poultry production, influenced by increasing consumer awareness
about food safety and quality. Producers are showing strong interest in
alternatives to conventional antibiotics, such as probiotics, herbal medicines,
and biologics, aligning with evolving consumer preferences. The expansion of
veterinary service networks, coupled with technological advancements in
diagnostics and digital monitoring, is enabling better disease control and
timely treatment adoption. Strategic investments from multinational
pharmaceutical companies into local markets are strengthening medicine
availability, while collaborations with regional research institutions are
fostering innovation tailored to local disease challenges. Furthermore, the
region is benefiting from supportive trade environments, as poultry exports
from Asia are growing steadily, driving the need for internationally compliant
veterinary practices.
Major
companies operating in Global Poultry Medicine Market are:
- Boehringer
Ingelheim International GmbH
- Zoetis
Services LLC
- Vaxxinova
International BV
- Merck
& Co., Inc.
- Calier
S.A.
- Elanco
Animal Health Incorporated
- Hester
Biosciences Limited
- Ceva
Santé Animale
- Phibro
Animal Health Corporation
- Kemin
Industries, Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Poultry Medicine Market is
expanding due to the rapid adoption of precision livestock farming
technologies, which are transforming poultry health management by integrating
digital monitoring systems, sensors, and artificial intelligence into farm
operations. These technologies allow real-time tracking of flock behavior, feed
intake, and environmental conditions, enabling early identification of health
issues before they escalate into widespread outbreaks. By supporting timely
intervention and optimized medicine administration, precision tools reduce
mortality, improve feed efficiency, and enhance overall productivity. This
approach not only lowers costs for producers but also ensures compliance with
rising food safety and sustainability standards.,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Poultry Medicine Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Species (Chicken, Turkey, Ducks, Others), By Product (Biologics,
Pharmaceuticals, Medicated Feed Additives), By Disease (Newcastle Disease,
Infectious Bronchitis, Infectious Bursal Disease, Coccidiosis, Salmonella,
Marek's Disease, Others), By Distribution Channel (Veterinary Hospitals &
Clinics, E-commerce, Offline Retail Stores, Others), By Region &Competition,
2020-2030F”, has evaluated the future growth potential of Global
Poultry Medicine Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Poultry
Medicine Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com